KATP Channels in Vascular Smooth Muscle: Structure, Regulation and Functional Roles

Journal of Clinical and Basic Cardiology

Volumn 6, Issue 1-4, 2003, Pages 7-14

  Standen, N B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

AKAP; Blood flow; Coronary blood flow; Exercise; KATP channel; Shock; Smooth muscle; Vasoconstriction; Vasodilation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCINEURIN; CALCINEURIN INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLOSPORIN A; DIAZOXIDE; GLIBENCLAMIDE; LEMAKALIM; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; NICORANDIL; PINACIDIL; POTASSIUM CHANNEL; TACROLIMUS;

BLOOD FLOW; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CHEMICAL COMPOSITION; CORONARY ARTERY BLOOD FLOW; DRUG POTENCY; EXERCISE; HUMAN; MEMBRANE PERMEABILITY; METABOLIC REGULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SHOCK; VASODILATATION;

EID: 0347384145     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997; 77: 1165-232.
2. Clapp LH, Tinker A. Potassium channels in the vasculature. Curr Opin Nephrol Hypertens 1998; 7: 91-8.
3. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 1998; 274: C25-C37.
4. ATP channels. Physiol Rev 1998; 78: 227-45.
5. + channels. Trends Neurosci 1998; 217: 288-94.
6. ATP channels. Neuron 1999; 22: 537-48.
7. + channels in the absence of the sulphonylurea receptor. Nature 1997; 387: 179-83.
8. ATP channels learned from Kir6.2 genetically engineered mice. Diabetes 2000; 493: 311-8.
9. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E, Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res 2001; 88: 570-7.
10. Koh SD, Bradley KK, Rae MG, Keef KD, Horowitz B, Sanders KM. Basal activation of ATP-sensitive potassium channels in murine colonic smooth muscle cell. Biophys J 1998; 75: 1793-800.
11. ATP) expressed in guinea pig bladder smooth muscle cells. J Pharmacol Exp Ther 1999; 289: 551-8.
12. + channels in smooth muscle cells from pig urethra. Br J Pharmacol 2000; 131: 505-13.
13. Beech DJ, Zhang H, Nakao K, Bolton TB. Single channel and whole-cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein. Br J Pharmacol 1993; 110: 583-90.
14. Beech DJ, Zhang H, Nakao K, Bolton TB. K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol 1993; 110: 573-82.
15. Zhang H, Bolton TB. Activation by intracellular GDP, metabolic inhibition and pinacidil of a glibenclamide-sensitive K-channel in smooth muscle cells of rat mesenteric artery. Br J Pharmacol 1995; 114: 662-72.
16. Inagaki N, Tsuura Y, Namba N, Masuda K, Gonoi T, Horie M, Seino Y, Mizuta M, Seino S. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 1995; 270: 5691-4.
17. + channel. J Biol Chem 1996; 271: 24321-4.
18. + channel. J Physiol 1997; 499: 715-20.
19. ATP channels in human pulmonary artery smooth muscle cells and their modulation by growth. Am J Respir Cell Mol Biol 2002; 26: 135-43.
20. Cui Y, Giblin JP, Clapp LH, Tinker A. A mechanism for ATP-sensitive potassium channel diversity: Functional coassembly of two pore-forming subunits. Proc Natl Acad Sci U S A 2001; 98: 729-34.
21. ATP channels more complex than originally thought? J Mol Cell Cardiol 2001; 33: 1541-6.
22. + channels. Receptors Channels 1998; 6: 129-40.
23. Repunte VP, Nakamura H, Fujita A, Horio Y, Findlay I, Pott L, Kurachi Y. Extracellular links in Kir subunits control the unitary conductance of SUR/Kir6.0 ion channels. EMBO J 1999; 18: 3317-24.
24. ATP channel subunits Kir6.1 and Kir6.2. J Biol Chem 2000; 275: 17561-5.
25. ATP currents by gene transfer of a dominant negative Kir6.2 construct. Pflugers Arch 1998; 436: 957-61.
26. ATP channel openers in the vascular smooth muscle cell tine, A10. Br J Pharmacol 1997; 122: 1119-26.
27. + channels. Nature 1990; 344: 770-3.
28. Dart C, Standen NB. Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J Physiol 1993; 471: 767-86.
29. + channels by cyclic AMP-dependent protein kinase in cultured smooth muscle cells of porcine coronary artery. Biochem Biophys Res Commun 1993; 193: 240-7.
30. + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 1998; 507: 117-29.
31. + currents in rabbit arterial smooth muscle via protein kinase A. J Physiol 1994; 475: 9-13.
32. Kleppisch T, Nelson MT. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 1995; 92: 12441-5.
33. Lin YF, Jan YN, Jan LY. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J 2000; 19: 942-55.
34. ATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Cell Physiol 2001; 530: 193-205.
35. Somlyo AP. Excitation-contraction coupling and the ultrastructure of smooth muscle. Circ Res 1985; 57: 497-507.
36. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 1990; 259: C3-C18.
37. Sanders KM. Invited review: mechanisms of calcium handling in smooth muscles. J Appl Physiol 2001; 91: 1438-49.
38. 2+ channels and K+ channels in smooth muscle cells. Pharmacol Ther 1997; 73: 91-119.
39. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 1992; 70: 612-6.
40. +-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol 1992; 263: H491-H496.
41. + channels in arterial smooth muscle through protein kinase C. J Gen Physiol 1996; 108: 315-23.
42. + currents in rat arterial smooth muscle cells through protein kinase C. J Physiol 1997; 503: 489-96.
43. NDP subtype of vascular smooth muscle ATP-sensitive potassium channel. Circ Res 2000; 87: 112-7.
44. Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ. Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci U S A 2000; 97: 9058-63.
45. + channels: role of protein phosphatase-2B. Circ Res 2000; 87: 1019-25.
46. Rubin CS. A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim Biophys Acta 1994; 1224: 467-79.
47. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278: 2075-80.
48. Colledge M, Scott JD. AKAPs: from structure to function. Trends Cell Biol 1999; 9: 216-21.
49. Rosenmund C, Carr DW, Bergeson SE, Nilaver G, Scott JD, Westbrook GL. Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 1994; 368: 853-6.
50. 2+ channels in rabbit portal vein. Am J Physiol 1999; 277: C840-C844.
51. Dart C, Leyland ML. Targeting of an A Kinase-anchoring Protein, AKAP79, to an inwardly rectifying potassium channel, Kir2.1. J Biol Chem 2001; 276: 20499-505.
52. ATP channels by protein kinase A. J Physiol 2001; 536: 421-7.
53. Carr DW, Stofko-Hahn RE, Fraser ID, Bishop SM, Acott TS, Brennan RG, Scott JD. Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif. J Biol Chem 1991; 266: 14188-92.
54. Klauck TM, Faux MC, Labudda K, Langeberg LK, Jaken S, Scott JD. Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 1996; 271: 1589-92.
55. Dodge K, Scott JD. AKAP79 and the evolution of the AKAP model. FEBS Lett 2000; 476: 58-61.
56. Itoh T, Furukawa K, Kajiwara M, Kitamura K, Suzuki H, Ito Y, Kuriyama H. Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries. J Pharmacol Exp Ther 1981; 218: 260-70.
57. Furukawa K, Itoh T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, Kuriyama H. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 1981; 218: 48-59.
58. Hamilton TC, Weir SW, Weston AH. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 1986; 88: 103-11.
59. Weir SW, Weston AH. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol 1986; 88: 121-8.
60. Bray KM, Newgreen DT, Small RC, Southerton JS, Taylor SG, Weir SW, Weston AH. Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate. Br J Pharmacol 1987; 91: 421-9.
61. Cook NS, Quast U, Hof RP, Baumlin Y, Pally C. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol 1988; 11: 90-9.
62. +-selective channels causing hyperpolarization and relaxation of noradrenaline contractions in rat mesenteric resistance vessels. Br J Pharmacol 1988; 95: 103-8.
63. Sassen LM, Duncker DJ, Gho BC, Diekmann HW, Verdouw PD. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs. Br J Pharmacol 1990; 101: 605-14.
64. + ATP channels. Am J Physiol 1991; 260: H957-H966.
65. Sato K, Kanatsuka H, Sekiguchi N, Akai K, Wang Y, Sugimura A, Kumagai T, Komaru T, Shirato K. Effect of an ATP sensitive potassium channel opener, levcromakalim, on coronary arterial microvessels in the beating canine heart. Cardiovasc Res 1994; 28: 1780-6.
66. + ATP channels in coronary vasodilation during exercise. Circulation 1993; 88: 1245-53.
67. + channel blockers on vascular tone in the perfused rat lung. Am Rev Respir Dis 1991; 144: 884-7.
68. ATP-channel activation causes marked vasodilation in the hypertensive neonatal pig lung. Am J Physiol 1992; 263: H1532-H1536.
69. Moreau R, Komeichi H, Kirstetter P, Yang S, Aupetit-Faisant B, Cailmail S, Lebrec D. Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats. Br J Pharmacol 1994; 112: 649-53.
70. Gardiner SM, Kemp PA, March JE, Fallgen B, Bennett T. Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats. Br J Pharmcol 1996; 117: 507-15.
71. Parekh N, Zou AP. Role of prostaglandins in renal medullary circulation: response to different vasoconscrictors. Am J Physiol 1996; 271: F653-F658.
72. Jackson WF. Arteriolar tone is determined by activity of ATP-sensitive potassium channels. Am J Physiol 1993; 265: H1797-H1803.
73. Vanelli G, Chang HY, Gatensby AG, Hussain SN. Contribution of potassium channels to active hyperemia of the canine diaphragm. J Appl Physiol 1994; 76: 1098-105.
74. Comtois A, Sinderby C, Comtois N, Grassino A, Renaud JM. An ATP-sensitive potassium channel blocker decreases diaphragmatic circulation in anesthetized dogs. J Appl Physiol 1994; 77: 127-34.
75. ATP channels. J Pharm Pharmacol 1995; 47: 243-5.
76. ATP channel antagonist, in the pulmonary and hindlimb circulation. Am J Physiol 1996; 271: L924-L931.
77. Thomas GD, Hansen J, Victor RG. ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 1997; 99: 2602-9.
78. Seki S, Sato K, Nakayama M, Murray PA. Halothane and enflurane attentuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state. Anesthesiology 1997; 86: 923-35.
79. ATP channels in regulation of systemic, pulmonary, and coronary vasomotor tone in exercising swine. Am J Physiol Heart Circ Physiol 2001; 280: H22-H33.
80. Imamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol 1992; 263: H399-H404.
81. Samaha FF, Heineman FW, Ince C, Fleming J, Balaban RS. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol 1992; 262: C1220-C1227.
82. Mori H, Chujo M, Tanaka E, Yamakawa A, Shinozaki Y, Mohamed MU, Nakazawa H. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel. Am J Physiol 1995; 268: H1077-H1085.
83. Narishige T, Egashira K, Akatsuka Y, Imamura Y, Takahashi T, Kasuya H, Takeshita A. Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs. Am J Physiol 1994; 266: H84-H92.
84. Jackson WF, Konig A, Dambacher T, Busse R. Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am J Physiol 1993; 264: H238-H243.
85. + channel activation. Am J Physiol 1993; 265: H1289-H1293.
86. Randall MD. The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart. Br J Pharmacol 1995; 116: 3068-74.
87. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of inward rectifier Kir6.1. Nature Medicine 2002; 8: 466-72.
88. ATP channels. J Clin Invest 2002; 110: 203-8.
89. ATP channels, adenosine, nitric oxide and prostaglandins. Br J Pharmacol 2001; 132: 1209-16.
90. Bank AJ, Sih R, Mullen K, Osayamwen M, Lee PC. Vascular ATP-dependent potassium channels, nitric oxide, and human forearm reactive hyperemia. Cardiovasc Drugs Ther 2000; 14: 23-9.
91. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 1998; 78: 53-97.
92. Reid JM, Paterson DJ, Ashcroft FM, Bergel DH. The effect of tolbutamide on cerebral blood flow during hypoxia and hypercapnia in the anaesthetized rat. Pflugers Arch 1993; 425: 362-4.
93. + channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol 1994; 267: H580-H586.
94. + channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res 1994; 74: 1005-8.
95. Reid JM, Davies AG, Ashcroft FM, Paterson DJ. Effect of L-NMMA, cromakalim, and glibenclamide on cerebral blood flow in hypercapnia and hypoxia. Am J Physiol 1995; 269: H916-H922.
96. + channels. Am J Physiol 1995; 269: H997-1002.
97. Armstead WM. Relationship among NO, the KATP channel, and opioids in hypoxic pial artery dilation. Am J Physiol 1998; 275: H988-H994.
98. Lee WS, Kwon YJ, Yu SS, Rhim BY, Hong KW. Disturbances in autoregulatory responses of rat pial arteries by sulfonylureas. Life Sci 1993; 52: 1527-34.
99. ATP channel blockade. J Clin Invest 1995; 95: 285-95.
100. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 1998; 82: 346-59.
101. ATP channels and adenosine in regulation of coronary blood flow in the hypertrophied left ventricle. Am J Physiol 1999; 277: H617-H625.
102. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-95.
103. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 1992; 89: 2071-4.
104. Wu CC, Thiemermann C, Vane JR. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol 1995; 114: 1273-81.
105. Vanelli G, Hussain SN, Aguggini G. Glibenclamide, a blocker of ATP-scnsitive potassium channels, reverses endotoxin-induced hypotension in pig. Exp Physiol 1995; 80: 167-70.
106. Vanelli G, Hussain SN, Dimori M, Agugoni G. Cardiovascular responses to glibenclamide during endotoxaemia in the pig. Vet Res Commun 1997; 21: 187-200.
107. Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol 1999; 128: 1772-8.
108. Sorrentino R, d'Emmanuele d, V, Lippolis L, Sorrentino L, Autore G, Pinto A. Involvement of ATP-sensitive potassium channels in a model of a delayed vascular liyporeactivity induced by lipopolysaccharide in rats. Br J Pharmacol 1999; 127: 1447-53.
109. + channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence. Br J Pharmacol 2000; 131: 213-22.
110. Szabo C, Salzman AL. Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. Shock 1996; 5: 391-4.
111. Pieber D, Horina G, Sandner-Kiesling A, Pieber TR, Heinemann A. Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats. Cardiovasc Res 1999; 44: 166-75.
112. ATP-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock. Am J Physiol 1997; 272: H688-H694.
113. Zhao K, Liu J, Jin C. The role of membrane potential and calcium kinetic changes in the pathogenesis of vascular hyporeactivity during severe shock. Chin Med J (Engl) 2000; 113: 59-64.
114. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 1994; 28: 45-79.
115. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol 1992; 105: 429-35.
116. Murphy ME, Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol 1995; 486: 47-58.
117. + channels in cGMP-mediated pial artery vasodilation. Am J Physiol 1996; 270: H423-H426.
118. + channel of vascular smooth muscle cells. FEBS Lett 1994; 345: 47-9.
119. + channels. Am J Physiol 1996; 271: H1498-H1506.
120. ATP channel partially reverses endotoxin-induced vascular hyporeactivity in rat superior mesenteric artery. Br J Pharmacol 2002; 135: 116P.
121. + channel inhibitors have variable effects on relaxation to L-arginine in LPS-treated rat aortic rings. Br J Pharmacol 2002; 135: 117P.
122. Griffin EC, Aiyar N, Slivjak MJ, Smith EF, III. Effect of endotoxicosis on plasma and tissue levels of calcitonin gene-related peptide. Circ Shock 1992; 38: 50-4.
123. Huttemeier PC, Ritter EF, Benveniste H. Calcitonin gene-related peptide mediates hypotension and tachycardia in endotoxic rats. Am J Physiol 1993; 265: H767-H769.
124. Arden WA, Fiscus RR, Wang X, Yang L, Maley R, Nielsen M, Lanzo S, Gross DR. Elevations in circulating calcitonin gene-related peptide correlate with hemodynamic deterioration during endotoxic shock in pigs. Circ Shock 1994; 42: 147-53.
125. Davie CS, Standen NB. Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery. Cardiovasc Res 1998; 37: 791-8.
126. Gomma AH, Purcell HJ, Fox KM. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil. Drugs 2001; 61: 1705-10.
127. Brady PA, Terzic A. The sulfonylurea controversy: more questions from the heart. J Am Coll Cardiol 1998; 31: 950-6.
128. Klamann A, Sarfert P, Launhardt V, Schulte G, Schmiegel WH, Nauck MA. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide). Eur Heart J 2000; 21: 220-9.